Body mass index and mortality in patients with schizophrenia spectrum disorders: a cohort study in a South London catchment area

Jianhua Chen, Gayan Perera, Hitesh Shetty, Matthew Broadbent, Yifeng Xu, Robert StewartGeneral 2022 · DOI

TL;DR

This study investigates the complex relationship between body mass index (BMI) and mortality in individuals with schizophrenia spectrum disorders (SSD). It reveals that while obesity is a significant risk factor for premature death in younger adults with SSD, being underweight emerges as a more prominent mortality risk factor in older individuals, potentially linked to frailty.

What Problem Does This Paper Address?

Individuals with schizophrenia spectrum disorders (SSD) experience a significantly higher rate of premature mortality compared to the general population, with estimates suggesting a reduction in life expectancy of 15-25 years. A substantial portion of this excess mortality is attributed to comorbid physical illnesses, including cardiovascular disease, type 2 diabetes, respiratory diseases, and certain cancers. Obesity is a known contributor to these conditions and is more prevalent in individuals with SSD. However, the specific role of body size, encompassing both underweight and overweight/obese states, as an independent risk factor for mortality in this vulnerable population has not been thoroughly evaluated. This paper aims to fill this gap by examining the associations between routinely recorded body size and all-cause mortality, as well as deaths from common causes, in a large cohort of individuals with SSD.

Methods

The researchers conducted a retrospective observational cohort study using data from the South London and Maudsley (SLaM) National Health Service Foundation Trust's Clinical Record Interactive Search (CRIS) platform. This platform contains de-identified electronic health records for approximately 1.3 million residents in southeast London.

The study population comprised individuals aged 18 years and older diagnosed with schizophrenia spectrum disorders between January 2007 and March 2018. Body Mass Index (BMI) was extracted using a bespoke Natural Language Processing (NLP) algorithm applied to the CRIS database, categorizing individuals into: underweight (<18.5), healthy weight (18.5–24.9), overweight (25–29.9), obese (30–39.9), and morbidly obese (40+). Mortality data was obtained through linkage to national death registrations.

Cox proportional hazards regression models were employed to assess the association between BMI categories and mortality. These models were adjusted for a comprehensive set of covariates, including sociodemographic factors (age, gender, ethnicity, marital status, living alone, employment status, socioeconomic status), lifestyle factors (smoking status), clinical factors (individual Health of the Nation Outcome Scale (HONOS) problems, medication groups), and comorbidities (hospitalised diabetes, hypertension, hyperlipidaemia). Analyses were conducted for all ages and then stratified by age groups (18-45 years, 45-64 years, and 65+ years) and by cause of death.

Datasets

The primary dataset used was the South London and Maudsley (SLaM) National Health Service Foundation Trust's Clinical Record Interactive Search (CRIS) platform. This platform contains de-identified electronic health records. Mortality data was linked from national death registrations held by the Office for National Statistics.

Key Insights and Ideas

  • Age-Dependent Mortality Risk: The most striking insight is the differential impact of body size on mortality based on age. This challenges a simplistic view of obesity as universally detrimental across all age groups within this population.
  • Underweight as a Frailty Indicator: The strong association between underweight status and mortality, particularly in older individuals, suggests it may be a marker of underlying frailty or severe illness rather than an independent risk factor itself. This highlights the need to consider the broader clinical context when interpreting BMI in older adults with SSD.
  • Obesity's Impact on Premature Mortality: The study confirms that obesity is a significant contributor to premature mortality in younger adults with SSD, underscoring the importance of early intervention and weight management strategies.
  • Beyond Circulatory Causes: While cardiovascular disease is a leading cause of death in the general population and in individuals with SSD, this study found no direct association between BMI categories and circulatory disease mortality. Instead, the associations were more pronounced with respiratory disease mortality (for morbid obesity) and external-cause mortality (for overweight and obese status). This suggests that the pathways linking obesity to mortality in SSD may differ from those in the general population.
  • The "Obesity Paradox" in Context: The findings align with the concept of the "obesity paradox" in some respects, where overweight status was associated with lower mortality in older age groups, though this was not consistently observed across all analyses.

Key Results

  • In the fully adjusted model for all ages, underweight status was associated with a significantly higher risk of all-cause mortality (HR: 1.33, 95% CI: 1.01 to 1.76). Overweight status was associated with a lower risk (HR: 0.87, 95% CI: 0.75 to 0.99).
  • In the 18-45 years age group, obesity (HR: 1.24, 95% CI: 1.01 to 1.52) and morbid obesity (HR: 1.54, 95% CI: 1.03 to 2.42) were significantly associated with increased all-cause mortality.
  • In the 65+ years age group, underweight status was strongly associated with higher mortality (HR: 1.77, 95% CI: 1.17 to 2.67), while obesity was associated with lower mortality (HR: 0.66, 95% CI: 0.50 to 0.87).
  • Cancer mortality was raised in underweight individuals (HR: 1.93, 95% CI: 1.03 to 4.10).
  • Respiratory disease mortality was raised in those with morbid obesity (HR: 2.17, 95% CI: 1.02 to 5.22).
  • External-cause mortality was higher in overweight and obese groups compared to healthy weight individuals.

Limitations and Future Work

The authors acknowledge several limitations:

  • Generalizability: The SLaM catchment area is urban, which may limit generalizability to rural populations.
  • Cohort Specificity: The cohort consists of individuals receiving specialist mental healthcare, not those receiving primary care.
  • BMI Measurement: The study relied on measured BMI, meaning approximately half of eligible patients were excluded due to missing BMI data. Patients with a BMI measure were younger and potentially had higher service involvement.
  • Data Source: Data was drawn from routine administrative and clinical records, which may have limitations in completeness, accuracy, and consistency.
  • BMI as a Measure: BMI is a crude measure of obesity, and the authors suggest future research should consider waist circumference and waist-to-hip ratio.

Future work should focus on a deeper biological understanding of the relationship between body size, disease, and schizophrenia to improve clinical practice. Further investigation is needed to clarify whether the association between underweight and mortality in older adults reflects underlying comorbidity or direct effects of the mental disorder (e.g., self-neglect). Investigating the specific causes and underlying factors for increased external-cause mortality in overweight and obese individuals is also recommended.

Summary updated

Abstract

Overall, being underweight was associated with higher mortality in this disorder group; however, this was potentially accounted for by frailty in older age groups, and obesity was a risk factor for premature mortality in younger ages. The impact of obesity on life expectancy for people with schizophrenia spectrum disorders is clear from our findings. A deeper biological understanding of the relationship between these diseases and schizophrenia will help improve clinical practice.
BibTeX
@inproceedings{chen2022body,
  author = {Jianhua Chen and Gayan Perera and Hitesh Shetty and Matthew Broadbent and Yifeng Xu and Robert Stewart},
  title = {{Body mass index and mortality in patients with schizophrenia spectrum disorders: a cohort study in a South London catchment area}},
  booktitle = {General},
  year = {2022},
  doi = {10.1136/gpsych-2022-100819},
}

Loading related content...

Figure